These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20410322)

  • 1. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.
    Marchant BK; Reimherr FW; Robison RJ; Olsen JL; Kondo DG
    J Atten Disord; 2011 May; 15(4):295-304. PubMed ID: 20410322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oppositional defiant disorder in adults with ADHD.
    Reimherr FW; Marchant BK; Olsen JL; Wender PH; Robison RJ
    J Atten Disord; 2013 Feb; 17(2):102-13. PubMed ID: 22100691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
    Gadow KD; Nolan EE; Sverd J; Sprafkin J; Schneider J
    J Child Neurol; 2008 Sep; 23(9):981-90. PubMed ID: 18474932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.
    Reimherr FW; Williams ED; Strong RE; Mestas R; Soni P; Marchant BK
    J Clin Psychiatry; 2007 Jan; 68(1):93-101. PubMed ID: 17284136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.
    Wilens TE; Hammerness P; Martelon M; Brodziak K; Utzinger L; Wong P
    J Clin Psychiatry; 2010 May; 71(5):548-56. PubMed ID: 20492851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
    Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R
    World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Types of adult attention-deficit hyperactivity disorder (ADHD): baseline characteristics, initial response, and long-term response to treatment with methylphenidate.
    Reimherr FW; Marchant BK; Gift TE; Steans TA; Wender PH
    Atten Defic Hyperact Disord; 2015 Jun; 7(2):115-28. PubMed ID: 25987323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
    Marchant BK; Reimherr FW; Halls C; Williams ED; Strong RE
    Ann Clin Psychiatry; 2010 Aug; 22(3):196-204. PubMed ID: 20680193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis.
    Van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Rev; 2008 Jun; 28(5):783-800. PubMed ID: 18068284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting.
    Pelham WE; Waxmonsky JG; Schentag J; Ballow CH; Panahon CJ; Gnagy EM; Hoffman MT; Burrows-MacLean L; Meichenbaum DL; Forehand GL; Fabiano GA; Tresco KE; Lopez-Williams A; Coles EK; González MA
    J Atten Disord; 2011 Jan; 15(1):28-35. PubMed ID: 20439487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.
    Goez H; Back-Bennet O; Zelnik N
    J Child Neurol; 2007 May; 22(5):538-42. PubMed ID: 17690058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD.
    Reimherr FW; Marchant BK; Williams ED; Strong RE; Halls C; Soni P
    Ann Clin Psychiatry; 2010 May; 22(2):103-12. PubMed ID: 20445837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing country.
    Chazan R; Borowski C; Pianca T; Ludwig H; Rohde LA; Polanczyk G
    J Clin Psychopharmacol; 2011 Jun; 31(3):309-17. PubMed ID: 21508864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed - Results from a randomized, double-blind, placebo-controlled clinical trial.
    Jahangard L; Akbarian S; Haghighi M; Ahmadpanah M; Keshavarzi A; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2017 May; 251():182-191. PubMed ID: 28213188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder.
    Murray DW; Childress A; Giblin J; Williamson D; Armstrong R; Starr HL
    Clin Pediatr (Phila); 2011 Apr; 50(4):308-20. PubMed ID: 21436147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.